EP2957278

IPSEN PHARMA
Application Number
EP15176548A
Filing Date
Oct 3, 2007
Status
Revoked
Nov 2, 2018
Grant Date
May 17, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2957278B1 was granted on May 17, 2017 by Ipsen Pharma The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ISENBRUCK BOSL HORSCHLERFeb 19, 2018ADMISSIBLE
TEVA PHARMACEUTICAL INDUSTRIESFeb 16, 2018ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionUS2002107200
N/A
OppositionWO03105772
N/A
OppositionWO9912561
N/A
OppositionWO9502610
N/A
OppositionWO9640775
N/A
OppositionEP0679088
N/A
OppositionUS6544949
N/A
OppositionUS6583114
N/A
OppositionEP1079803
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.